Active Surveillance Reduces the Incidence of Vancomycin-Resistant Enterococcal Bacteremia

Clinical Infectious Diseases

Volumn 37, Issue 7, 2003, Pages 921-928

  Price, Connie S ^a,b,c   Paule, Suzanne ^a,b,c   Noskin, Gary A ^a   Peterson, Lance R ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL TRANSMISSION; BLOOD FLOW; CLONE; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST;

EID: 0142075843     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377733     Document Type: Article

References (28)

1. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342:710-21.
2. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from October 1986-April 1998, issued June 1998. Available at: http://www.cdc.gov/ncidod/hip/NNIS/sar98net.pdf. Accessed May 2001.
3. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123:250-9.
4. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615-9.
5. Tucci V, Haran MA, Isenberg HD. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital. Am J Infect Control 1997; 25:371-6.
6. Keita-Perse O, Gaynes RP. Severity of illness scoring systems to adjust nosocomial infection rates: a review and commentary. Am J Infect Control 1996; 24:429-34.
7. Hacek DM, Suriano T, Noskin GA, Kruszynski J, Reisberg B, Peterson LR. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am J Clin Pathol 1999; 111:647-54.
8. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-33.
9. Grayson ML, Grabsch EA, Johnson PD, et al. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 1999; 171:133-6.
10. Hendrix CW, Hammond JM, Swoboda SM, et al. Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg 2001; 233:259-65.
11. Brown AR, Amyes SG, Paton R, et al. Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit. J Hosp Infect 1998; 40:115-24.
12. Byers K, Durbin L, Simonton M, Anglim A, Adal K, Farr B. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1998; 19:261-4.
13. Kim WJ, Weinstein RA, Hayden MK. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999; 179:163-71.
14. Northwestern Memorial Hospital: information about us. Statistics. Available at: http://www.nmh.org/about_nmh/index.html. Accessed May 2001.
15. About Rush. Available at: http://www.rpslmc.edu/general/about.html. Accessed May 2001.
16. Zembower T, Peters D, Dressel D, Noskin G, Thompson R, Peterson L. Development of a selective medium to detect both vancomycin-resistant enterococci (VRE) and gram-negative bacilli (GNB) containing extended-spectrum beta-lactamases (ESBLs) [abstract 743]. In: Program and abstracts of the 35th annual meeting of the Infectious Diseases Society of America (San Francisco). Alexandria, VA: Infectious Diseases Society of America, 1997:209.
17. Hacek DM, Trick WE, Collins SM, Noskin GA, Peterson LR. Comparison of the Rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant Enterobacteriaceae from environmental surfaces. J Clin Microbiol 2000; 38:4646-8.
18. Brown SD, Washington JA 2nd. Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol 1978; 8:695-9.
19. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS document no. M7-A3. Vulanova, PA: NCCLS, 1993.
20. Savor C, Pfaller MA, Kruszynski JA, Hollis RJ, Noskin GA, Peterson LR. Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data. J Clin Microbiol 1998; 36:3327-31.
21. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
22. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158:522-7.
23. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36:145-58.
24. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172:993-1000.
25. Newell KA, Millis JM, Arnow PM, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65:439-42.
26. Kapur D, Dorsky D, Feingold JM, et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 25:147-2.
27. Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22:207-9.
28. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001; 22:140-7.